Businesswire News Releases

Mar 28, 2024 16:05 ET
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced that Chirag and Chintu Patel, Co-founders and Co-Chief Executive Officers, will ring the Nasdaq closing bell on Tuesday, April 2, 2024....
Mar 28, 2024 16:05 ET
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2023....
Mar 28, 2024 16:05 ET
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three months and year ended December 31, 2023 and provides a business update....
Mar 28, 2024 16:05 ET
Energous Corporation Reports 2023 Results
Energous Corporation (NASDAQ: WATT), a leading developer of RF-based charging for wireless power networks, today announced financial results for the year ended December 31, 2023, and provided an update on recent partnerships and company highlights....
Mar 28, 2024 16:05 ET
Myomo Appoints Heather Getz to its Board of Directors
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors....
Mar 28, 2024 16:05 ET
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of the Grappler® R3INFORCE™ Extraosseous Repair System designed to restore stability to the anterior and posterior ligaments surrounding the ankle during fibula fracture repairs and high ankle sprains....
Mar 28, 2024 16:05 ET
Planet Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
Planet Labs PBC (NYSE: PL) (“Planet” or the “Company”), a leading provider of daily data and insights about Earth, today announced financial results for the period ended January 31, 2024....
Mar 28, 2024 16:05 ET
Planet to Provide Carbon Mapper, Inc. with Hyperspectral Data Until 2030
Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, today announced it has signed a multi-year data-license agreement with Carbon Mapper, Inc. to provide hyperspectral core imagery to the non-profit and its partners until 2030. The $20 million agreement is made possible by initial funding led by a major climate philan...
Mar 28, 2024 16:05 ET
Surf Air Mobility Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2023
Surf Air Mobility Inc. (NYSE: SRFM), a leading regional air mobility platform, today reported its fourth quarter and full year results. Please visit the Surf Air Mobility investor relations website at investors.surfair.com for more information and to listen to the accompanying earnings call at 5:00 pm eastern time....
Mar 28, 2024 16:05 ET
Torrid Reports Fourth Quarter and Fiscal 2023 Results and Initiates Fiscal 2024 Guidance
Torrid Holdings Inc. (“Torrid” or the “Company”) (NYSE: CURV), a direct-to-consumer apparel, intimates, and accessories brand in North America for women sizes 10 to 30, today announced its financial results for the quarter ended February 3, 2024....
Mar 28, 2024 16:05 ET
Utz Brands, Inc. Increases Quarterly Cash Dividend
Utz Brands, Inc. (NYSE: UTZ) (“Utz” or the “Company”), a leading U.S. manufacturer of branded salty snacks, today announced that its Board of Directors has approved an annual dividend increase from $0.228 to $0.236 per share. The increase is effective as of today, and the Utz Board of Directors (“Board”) has declared a regular quarterly cash dividend of approximately $0.059 per share on the Company’s Class A Common Stock. Payment is expected to be made by the Company on May 2, 2024, to stockholders of record at the close of business on April 15, 2024....
Mar 28, 2024 16:04 ET
Leafly Holdings, Inc. Announces Appointment of Two Cannabis Industry Veterans to Its Board
Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced the appointment of Jeffrey Monat and Andres Nannetti to its Board of Directors, effective March 25, 2024. Both individuals bring decades of operational and financial expertise to the board as the Company looks to build a more durable business and strengthen its financial position....
Mar 28, 2024 16:02 ET
Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the full year ended December 31, 2023, and provided an overview of recent developments....
Mar 28, 2024 16:02 ET
Leafly Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its fourth quarter and year ended December 31, 2023....
Mar 28, 2024 16:01 ET
Bristol Myers Squibb Provides Update on the First Phase 3 YELLOWSTONE Trial Evaluating Oral Zeposia (ozanimod) in Patients with Moderate to Severe Active Crohn’s Disease
Bristol Myers Squibb (NYSE: BMY) today announced an update following the initial analysis of results from the first of two induction studies in the Phase 3 YELLOWSTONE clinical trial program evaluating Zeposia (ozanimod) in adult patients with moderate to severe active Crohn’s disease. The study did not meet its primary endpoint of clinical rem...
Mar 28, 2024 16:01 ET
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended December 31, 2023....
Mar 28, 2024 16:01 ET
EACO Corporation Reports Record 2nd Quarter Net Sales and Record 2nd Quarter Net Income
EACO Corporation (OTCMKTS:EACO) today reported the results for its quarter ended February 29, 2024....
Mar 28, 2024 16:01 ET
Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10 at 1:30 p.m. Eastern Time....
Mar 28, 2024 16:00 ET
CVD Equipment Corporation Reports Fourth Quarter and Fiscal Year 2023 Financial Results
CVD Equipment Corporation (NASDAQ: CVV), today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023....
Mar 28, 2024 16:00 ET
Eaton Vance Closed-End Funds Release Estimated Sources of Distributions
The Eaton Vance closed-end funds listed below released today the estimated sources of their March distributions (each a “Fund”). This press release is issued as required by the Funds’ managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the Ma...